Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adultsCosibelimab PDUFA goal date of December 28 for ...

The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of ...

A doctor has offered guidance on managing a common skin condition that often worsens during the colder months. Sharing advice ...

The Food and Drug Administration has approved Emrosi ™ (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults. In ...

U.S. FDA approved Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea in adults; launch expected in late Q1 or early Q2 of 2025 ...

The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.

As more consumers seek solutions for redness-prone skin, the demand for effective, gentle ingredients is soaring. From environmental stressors to common irritants like acne and rosacea, sensitive skin ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...